Head and Neck Cancer Trial, Recruiting NCT07068711 Sponsor: Marmara University Condition: Head and Neck Cancer
Back to Head And Neck Cancer

Head and Neck Cancer Trial, Recruiting

NCT07068711
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 years or older
  • People who have been diagnosed with head and neck cancer
  • People who are receiving radiotherapy treatment at Marmara University Pendik Training and Research Hospital, Radiation Oncology Clinic
  • People who are willing to take part and can sign a written consent form
  • People who are able to communicate and cooperate during assessments

Who may not be able to join:

  • People for whom a body composition measurement (called BIA) cannot be performed — for example, those who have had caffeine in the last 4 hours, alcohol in the last 24 hours, intense exercise in the last 24–48 hours, are currently menstruating, or have a pacemaker or metal implants in their body
  • People who have difficulty communicating or who have cognitive impairments affecting their understanding
  • People who have had a limb amputation or who have severe deformities affecting the upper limbs
  • People who have neuromuscular disorders, hemiplegia (paralysis on one side of the body), rheumatoid arthritis, or moderate to severe neurological or cognitive conditions
  • People who are receiving nutrition delivered directly into a vein (called parenteral nutrition)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Beste M Atasoy, Prof. Dr., Marmara University

Phone: +905327070972

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Marmara University
Registry
ClinicalTrials.gov
Start date
1 July 2025
Est. completion
25 June 2026

Where this trial is recruiting

Turkey (Türkiye)

Primary endpoints

PG-SGA Score; Body Composition - BIA; Quality of Life - EORTC QLQ-H&N35; Handgrip Strength; Dietary Intake - 24-Hour Food Recall; Mid-Upper Arm Circumference (MUAC); Body Mass Index (BMI)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov